Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

Appili Therapeutics had revenue of 108.36K CAD in the quarter ending December 31, 2024, a decrease of -77.35%. This brings the company's revenue in the last twelve months to 124.75K, down -89.15% year-over-year. In the fiscal year ending March 31, 2024, Appili Therapeutics had annual revenue of 827.41K with 147.60% growth.

• Revenue (ttm): 124.75K
• Revenue Growth: -89.15%
• P/S Ratio: 24.30
• Revenue / Employee: n/a
• Employees: 9
• Market Cap: 3.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-
Mar 31, 2020	199.11K	-	-